Natural killer (NK) cells and dendritic cells (DC) are functionally diverse leukocytes. However, a population functionally astride both cell types has been described and termed interferon (IFN)-producing killer DC (IKDC). According to the original descriptions, these cells efficiently mediate both natural cytotoxicity and antigen presentation to CD4 T cells. Other authors have challenged the original observations with ontogeny and functional results, which concluded that these cells merely represent an activated status of NK cells. The CD45 isoform B220 is a surface marker used to distinguish both populations. The putative IKDC has been shown to be induced to proliferate and is activated by interleukin 15 (IL-15) as a recombinant protein or when the liver is gene transduced with an efficiently expressed IL-15 expression cassette. In this letter, we show that there are in vivo conditions of activation of spleen NK cells that do not result in surface expression of . DX5 + splenocytes from (CD45.1) mice were enriched by immunomagnetic selection (Miltenyi Biotec, Bergisch Gladbach, Germany). Cells were then stained with monoclonal antibodies (mAbs) anti-CD3, NK1.1, B220 and CD11c. Gated CD3 À NK1.1 + were sorted to 98-99% purity into B220 + and B220 À fractions (FACSAria; BD Biosciences, Madrid, Spain). (a) A total of 10 5 sorted cells, either B220 À (upper dot plots) or B220 + (middle dot plots), were transferred i.v. to congeneic CD45.2 C57/BL6 mice that had been injected by hydrodynamic injection 6 with 10 mg of the indicated plasmids. After 3 days, spleens were collected and carboxyfluorescein diacetate succinimidyl ester (CFSE) cells were analyzed for proliferation and B220 expression (BD Biosciences). Representative dot plots are shown. Results of two mice per group in three independently performed experiments rendered similar results. In the bottom, a colored overlay of the samples acquired under identical conditions is provided to facilitate comparison (red dots for IKDC and blue for NK cells). Isotype-matched fluorochrome-tagged control mAbs were used to verify B220 negativity and set the quadrants. B220 was confirmed to bind B cells in the same sample and anti-CD45.2 mAb co-staining was used to ensure the donor identity of the adoptively transferred cells. Mice without hydrodynamic injection of any plasmid showed no proliferation in the adoptively injected cells as in the control plasmid group (not shown). (b) A similar experiment to that shown in (a) but in which spleen collection in recipient mice was postponed day 5 after adoptive transfer. Recently, we reported that productive in vivo transfer of the IL-15 gene into the liver by hydrodynamic injection results in the proliferation and activation of both cNK cells and IKDC. 6 Furthermore, in the context of in vivo gene transfer of IL-15 into hepatocytes, 6 we made other observations centered on both the function and ontogeny of IKDC, which are relevant to this controversy. Immunostaining of the CD45.1/CD45.2 polymorphism permitted unequivocal gating of the adoptively transferred cells. As depicted in Figure 1a , a fraction of cNK cells proliferated several cycles for 3 days without acquisition of B220 surface expression on the vast majority of cells, whereas the anti-B220 antibody readily stained B cells from recipient mice in the same splenocyte preparation (not shown). In a parallel experiment (Figure 1a , middle dot plots), sorted IKDC showed a slightly higher proliferative response to IL-15 gene transfer and retained a bright B220 expression during the 3-day in vivo experiment. An overlay with colored dot plots from matched mice is given for comparison in Figure 1a (bottom dot plots, blue dots for conventional NK and red dots for IKDC). It could be argued that the in vivo proliferation time was not long enough. However, if the experiment had been extended to 5 days, more proliferation could have been substantiated among the cNK, without acquisition of a detectable B220 surface staining in the majority of proliferating cells.
To provide sorted cNK cells with an even stronger proliferative stimulus, they were transferred into Rag-2 À/À gc À/À BALB/c mice. In these conditions, a fast and strong proliferation of adoptive transfer of cNK cells is observed as a result of alloreactivity and lymphopenia of recipient mice. Even in this case, there was only a slight tendency to acquire B220 expression by proliferating NK cells. Similar results were found when cells were transferred into Rag-2gc À/À BALB/c mice receiving polyI:C (data not shown).
Interleukin-15 has been shown to be a major promoter of activation and proliferation for both NK cells and the putative IKDC cell sub-population. 6, 8, 9 The fact that cNK cells do not acquire B220 surface expression even when experiencing intense IL-15-dependent proliferation and activation in vivo supports the existence of differences between cNK and IKDC without interconversion at least under the described conditions of in vivo activation. According to our data, the B220 + cells that proliferate on IL-15 systemic delivery are not conventional B220
À NK cells that acquire B220 expression but cells that were expressing B220 before exposure to exogenous IL-15. However, the core of the controversy remains as to whether IKDC present antigen from the debris of the cells that they terminate and thereby prime specific T cells. In this regard, two recent papers provide evidence showing that IKDC are capable of efficient presentation of tumor and infectious antigens to CD4 + and CD8 + T cells. 10, 11 Moreover, IKDC show interesting and distinct migratory properties to tumor tissues and lymph nodes. 12 The fact that cNK cells do not acquire B220 expression even when experiencing intense IL-15-dependent proliferation and activation further supports the existence of differences between NK and IKDC.
